• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $APYX

    Apyx Medical Corporation

    Subscribe to $APYX
    $APYX
    Medical/Dental Instruments
    Health Care

    Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and OEM. It offers electrosurgical generators based on its Helium Plasma Technology for cutting, coagulation, and ablation of soft tissue. The company offers Renuvion branded products for the cosmetic surgery market that enable plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and J-Plasma branded products for the hospital surgical market that allows surgeons to operate with precision and eliminate unintended tissue trauma. It also develops, manufactures, and sells energy generators, disposable hand piece subassemblies, and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

    IPO Year:

    Exchange: NASDAQ

    Website: apyxmedical.com

    Recent Analyst Ratings for Apyx Medical Corporation

    DatePrice TargetRatingAnalyst
    10/17/2024Neutral
    BTIG Research
    7/14/2023$8.00Overweight
    Stephens
    5/20/2022$12.00Buy
    Lake Street
    8/13/2021$12.00 → $14.00Market Outperform
    JMP Securities
    See more ratings

    Apyx Medical Corporation Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Sr. V.P. of Operations Citronowicz Moshe

      4 - Apyx Medical Corp (0000719135) (Issuer)

      5/19/25 4:31:11 PM ET
      $APYX
      Medical/Dental Instruments
      Health Care
    • SEC Form 4 filed by Director Baylor-Henry Minnie

      4 - Apyx Medical Corp (0000719135) (Issuer)

      5/19/25 4:31:08 PM ET
      $APYX
      Medical/Dental Instruments
      Health Care
    • SEC Form 4 filed by Chief Financial Officer Hill Matthew C

      4 - Apyx Medical Corp (0000719135) (Issuer)

      5/19/25 4:31:12 PM ET
      $APYX
      Medical/Dental Instruments
      Health Care
    • SEC Form 4 filed by Director Waldman Lawrence

      4 - Apyx Medical Corp (0000719135) (Issuer)

      5/19/25 4:31:10 PM ET
      $APYX
      Medical/Dental Instruments
      Health Care
    • SEC Form 4 filed by Chief Executive Officer Goodwin Charles D. Ii

      4 - Apyx Medical Corp (0000719135) (Issuer)

      5/19/25 4:31:05 PM ET
      $APYX
      Medical/Dental Instruments
      Health Care
    • SEC Form 4 filed by Director Levine Wendy Lauren

      4 - Apyx Medical Corp (0000719135) (Issuer)

      5/19/25 4:31:03 PM ET
      $APYX
      Medical/Dental Instruments
      Health Care
    • SEC Form 4 filed by Director Vizirgianakis Stavros G.

      4 - Apyx Medical Corp (0000719135) (Issuer)

      5/19/25 4:31:06 PM ET
      $APYX
      Medical/Dental Instruments
      Health Care
    • Amendment: Chief Financial Officer Hill Matthew C bought $6,780 worth of shares (6,000 units at $1.13), increasing direct ownership by 240% to 8,500 units (SEC Form 4)

      4/A - Apyx Medical Corp (0000719135) (Issuer)

      3/3/25 4:05:12 PM ET
      $APYX
      Medical/Dental Instruments
      Health Care
    • SEC Form 4 filed by Chief Operating Officer Roman Shawn David

      4 - Apyx Medical Corp (0000719135) (Issuer)

      1/17/25 4:07:08 PM ET
      $APYX
      Medical/Dental Instruments
      Health Care
    • SEC Form 4 filed by Director Baylor-Henry Minnie

      4 - Apyx Medical Corp (0000719135) (Issuer)

      1/17/25 4:07:05 PM ET
      $APYX
      Medical/Dental Instruments
      Health Care